BMS backs Stand Up To Cancer lung research

The drug maker is kicking in $5 million—or 20% of funding—for the research "dream team," which is part of an alliance between Stand Up and the American Cancer Society.

January 29, 2014

7:08 pm

Bristol-Myers Squibb is kicking in $5 million to support a new lung cancer research “Dream Team.” The money is going toward a new collaboration between the American Cancer Society and the group Stand Up To Cancer.

The BMS contribution covers 20% of the Dream Team’s three-year research budget.

From Our Partners

HUB services, patient engagement, and specialty pharmacy: One patient support ecosystem with three core components

Partner Content

HUB services, patient engagement, and specialty pharmacy: One patient support ecosystem with three core components

The evolution of patient needs and rising consumer expectations are shaping a new era in healthcare — one that calls for a paradigm shift in the pharmaceutical industry's approach to patient support.

Omnichannel activation without omniburden

Partner Content

Omnichannel activation without omniburden

Explore solutions for practically implementing omnichannel approaches into your go-to-market activation.

Taking a patient-centric approach to privacy

Partner Content

Taking a patient-centric approach to privacy

This podcast will explore ways to deliver tailored content that activates, educates and empowers patients while prioritizing privacy and consent.

Living brands: How to build brands in the age of omnichannel

Partner Content

Living brands: How to build brands in the age of omnichannel

This podcast looks at how to leverage advancements in data, technology, AI and content development in order to become a Living Brand.